FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Timber Pharma Wins Orphan Status for Sitaxsentan

FDA grants Timber Pharmaceuticals an orphan drug designation for TMB-003, a locally delivered formulation of sitaxsentan, indicated for treating syste...

Human Drugs

FDA OKs Marinus Ganaxolone NDA Filing

FDA tells Marinus that Marigold study data appear sufficient to justify filing an NDA for oral ganaxolone to treat children and adults with CDKL5 defi...

Human Drugs

Leading BioSciences Fast Track for GI Dysfunction

FDA grants Leading BioSciences a fast track designation for LB1148 for treating postoperative gastrointestinal dysfunction associated with pediatric h...

Biologics

Slaoui Resigns from Warp Speed at Biden Team Request: Report

CNBC reports that Operation Warp Speed chief adviser Moncef Slaoui has resigned at the request of the incoming Biden administration.

FDA General

HHS Transparency, Fairness Rule

HHS issues an additional final rule amplifying an earlier good guidance practices rule.

Federal Register

Info Collection Extension for Extralabel Drug Use

Federal Register notice: FDA sends to OMB an information collection extension for Extralabel Drug Use for Animals 21 CFR 530.

Human Drugs

SCOTUS Backs FDA Mifepristone Requirement

Splitting along ideological lines, the Supreme Court says FDA can enforce a requirement that women seeking a medication abortion must obtain mifeprist...

Medical Devices

FDA Artificial Intelligence Action Plan Outlined

Two SheppardMullin attorneys outline the contents of an FDA action plan for artificial intelligence/machine learning.

Medical Devices

STeP Requests Start 3/8: Report

Two Hogan Lovells attorneys describe provisions in an FDA final guidance on the voluntary STeP program for medical devices.

Human Drugs

Generic Zantac Suit Falls to Preemption

A Florida federal court throws out multidistrict litigation against manufacturers and distributors of generic Zantac.